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BACKGROUND/OBJECTIVES: With any emergency situation, the role of healthcare workers and first responders is of paramount importance and often exposes them to various unidentified hazards. In recent years, several threats to human health have involved emerging viruses unknown to the human immune system, therefore causing severe diseases with high fatality rates. Examples of such diseases causing viral agents include the SARS coronavirus and the avian influenza A/H5N1, as well as Variola major (smallpox), considered a highly potent bioterrorism tool. All have dramatically amplified the menace pending over these responders and their increasing need for proper respiratory protection, well illustrated by the SARS Commission Final Report on the Toronto outbreak, which concludes that healthcare workers were inadequately protected by authorities. Because of their role, respiratory protection for healthcare workers is of utmost importance and requires the highest possible level of protection, provided by such devices as Self-Contained Breathing Apparatus (SCBAs) or Powered Air Purifying Respirators (PAPRs). However, this type of equipment does not allow for easy stockpiling, and their use might not be realistic in all situations. Most occupational health authorities thus recommend the use of NIOSH certified N95 respirators in situations suspected of involving an airborne infectious hazard. N95 certification requires particulate filtration efficiencies of 95% against an aerosol of inert particles with a mean particle size of 0.3 μm. Considering that most viruses of pathogenic concern are smaller than 0.3 μm, and that the most penetrating particle size through charged fibers shifts towards the nano-sized range, this represents insufficient protection. We combined an iodinated bioactive polymer to the mechanical filtration equivalent of an N95, developing a respirator offering enhanced protection against airborne viruses.

METHODS: Viral Reduction Efficiency (VRE) of respirators was evaluated by full-sized device testing against a viral surrogate, MS2 coliphage (0.25 μm), and an animal virus, human influenza A/H1N1 (0.08-0.12 μm). Collison nebulizers generate a bioaerosol containing 10^4^ to 10^6^ PFU/m^3^ of air, which is then drawn through the respirators at a flow rate of 85 LPM. Effluent is recovered in All Glass Impingers containing phosphate buffer. Studies are usually performed in ambient conditions, although some tests were done at various environmental conditions.

RESULTS: The Iodinated Polymer-containing (IPC) respirator was assessed for its VRE alongside commercial NIOSH-certified respirators in ambient conditions. Against both viral challenges, the IPC demonstrated higher VRE values than other respirators, reducing the viral concentrations by an additional 1 to 3 logs. Similar results were obtained at various environmental conditions.

CONCLUSIONS: The inclusion of a biocide has been shown to improve the VRE performance of the respirator. Our method does not account for fit factor; fit testing should be performed to ensure a proper fit, and thus efficacy of the respirator.
